Skip to main content
OpenTrials
Completed

NCT Number: NCT05597787

HIV-Related Stigma Intervention for Malaysian Clinicians

Key populations at risk of HIV (including men who have sex with men, people who inject drugs, transgender women, and female sex workers) are more likely to be infected with HIV but less likely than members of the general population to know of their HIV status, receive HIV prevention counseling, or be linked to HIV care services. Clinician stigma towards these groups remains a potent and persistent driver of these HIV disparities in many places of the world. The investigators propose to incorporate evidence-based stigma reduction tools into a popular teletraining platform for clinicians and pilot test the resulting intervention (Project ECHO® for HIV Prevention and Stigma Reduction) with clinicians in Malaysia, a context wherein clinician stigma and HIV disparities are substantial.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Acquired Immunodeficiency Syndrome Blood-Borne Infections Communicable Diseases Genital Diseases HIV Infections Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Malaya

Kuala Lumpur, Malaysia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • practicing general practitioner or family medicine specialist in Malaysia

Exclusion criteria

-

Treatment and study plan

HIV Connect

Behavioral

online education and clinical skills

Project ECHO for HIV Prevention

Behavioral

education and clinical skills

Project ECHO for HIV Prevention and Stigma Reduction

Behavioral

education, clinical skills and contact

Primary outcomes

  1. Acceptability of Intervention

    Time frame: Month 9 Assessment

    Measured with Acceptability of Intervention Measure. Theoretical or possible range of scores is 1-5, and actual range was 3.50-5. Higher scores indicate greater acceptability.

  2. Feasibility of Intervention

    Time frame: Month 9 Assessment

    Measured with Feasibility of Intervention Measure. Theoretical or possible range of scores is 1-5, and actual range was 3.25-5. Higher scores indicate greater feasibility.

  3. Stigma Reduction: Prejudice

    Time frame: Month 9 Assessment

    Measured with Feelings Thermometers. Positive/Negative affect is measured on 0-100 point scale, with higher scores indicating more prejudice.

  4. Stigma Reduction: Stereotypes

    Time frame: Month 9 Assessment

    Measured with subscale of Multidimensional HIV-Related Stigma Scale. Theoretical or possible range of scores is 1-5, and actual range was 1-3.44. Higher scores indicate greater stereotypes.

  5. Stigma Reduction: Discrimination

    Time frame: Month 9 Assessment

    Measured with subscale of Multidimensional HIV-Related Stigma Scale. Theoretical or possible range of scores is 1-5, and actual range was 1-5. Higher scores indicate greater discrimination.

Secondary outcomes

  1. HIV Prevention Procedures: HIV Testing

    Time frame: Cumulative over 9 month intervention

    Measured with weekly diary of HIV tests performed. Number of HIV tests will be summed over duration of intervention.

  2. HIV Prevention Procedures: PrEP Prescriptions

    Time frame: Cumulative over 9 month intervention

    Measured with weekly diary of PrEP prescriptions. Number of PrEP prescriptions will be summed over duration of intervention.

Sponsors and collaborators

Lead sponsor

University of Delaware

Other

Collaborators

  • University of Malaya

Registry information

Official study title

Implementing Stigma Reduction Tools Via a Popular Teletraining Platform to Reduce Clinician Stigma and Disparities in HIV Testing, Prevention, and Linkage to Care in Malaysia

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Oct 28, 2022
Registry last updated
Dec 11, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.